Key result
Anti-HAV prevalence reaches ~58% in Suriname emergency patients, linked to older age and specific ethnicities.
Why the study?
Hepatitis A virus and hepatitis E virus cause acute hepatitis in low- and middle-income countries, but prevalence data in Suriname are scarce.
Cross-Sectional (n=949)
No
In Suriname, HAV exposure is consistent with a very low endemic country and HEV exposure is rare, with higher prevalence in specific ethnic groups and older age.
Younger patients may remain HAV-susceptible; leaves open whether ethnicity-targeted vaccination warrants prospective evaluation in Suriname.
BACKGROUND: Hepatitis A virus (HAV) and hepatitis E virus (HEV) have enteric modes of transmission and are common causes of acute hepatitis in low- and middle-income countries. HEV is also characterised as a zoonotic infection and is prevalent in high-income countries. Data on HAV and HEV prevalence in Suriname, a middle-income country in South America, are scarce. METHODS: Serum samples of 944 and 949 randomly selected patients attending the Emergency Department at the Academic Hospital of Paramaribo, the capital of Suriname, were analysed for anti-HAV antibodies (anti-HAV) and anti-HEV antibodies (anti-HEV), respectively. Determinants of anti-HAV and anti-HEV positive serology were evaluated using multivariable logistic regression. RESULTS: Anti-HAV prevalence was 58.3% (95% CI 55.4 to 61.4%) and higher prevalence was independently associated with belonging to the Tribal or Indigenous population and older age. Anti-HEV prevalence was 3.7% (95% CI 2.6 to 5.0%) and higher prevalence was associated with Tribal and Creole ethnicity and older age. CONCLUSIONS: In Suriname, exposure to HAV is consistent with a very low endemic country and exposure to HEV was rare. Both viruses were more prevalent in specific ethnic groups. As anti-HAVantibodies were less frequently found in younger individuals, they could be susceptible to potential HAV outbreaks and might require HAV vaccination.
No takes yet. Share an insight, caveat, or question.
Donald-Ottevanger et al. (2022) conducted a cross-sectional in Hepatitis A and E virus seroprevalence (n=949). Ethnic background and age was evaluated on Anti-HAV seroprevalence (95% CI 55.4-61.4). Anti-HAV prevalence was 58.3% and anti-HEV prevalence was 3.7% among emergency department patients in Suriname, with higher prevalence associated with specific ethnic groups and older age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: